National Research Corp (NRC) support and resistance · P/E 46, rev $143.1M
National Research Corp (NRC) is a health information services company listed on NASDAQ.
This page maps National Research Corp (NRC) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported NRC revenue for 2024-12-31 was $143.1M. Net income was $24.8M. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. NRC currently screens at market cap $400.0M and trailing P/E 45.5.
NRC currently screens at market cap $400.0M and trailing P/E 45.5. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new NRC 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the NRC quote page for the session range and the stock page for the full model.
Not investment advice.